Caveolins sequester FA on the cytoplasmic leaflet of the plasma membrane, augment triglyceride formation, and protect cells from lipotoxicity

Journal of Lipid Research

Volumn 51, Issue 5, 2010, Pages 914-922

  Simard, Jeffrey R ^a,b   Meshulam, Tova ^a   Pillai, Biju K ^a   Kirber, Michael T ^a   Brunaldi, Kellen ^a   Xu, Su ^a   Pilch, Paul F ^a   Hamilton, James A ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHEMICAL GENOMICS CENTRE OF THE MAX PLANCK SOCIETY   (Germany)

Author keywords

Caveolae; Caveolin 1; Caveolin 3; Cholesterol; Fatty acid; Lipid raft; Transport

Indexed keywords

ARGININE; CAVEOLIN 1; CAVEOLIN 3; FATTY ACID; FLUORESCENT DYE; LYSINE; PHOSPHATIDYLETHANOLAMINE;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL LABELING; CELL MEMBRANE; CELL PH; CELL PROTECTION; CELL STRAIN HEK293; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOTOXICITY; FATTY ACID METABOLISM; FATTY ACID TRANSPORT; HUMAN; HUMAN CELL; LIPID ANALYSIS; LIPID RAFT; LIPID STORAGE; LIPOGENESIS; MEMBRANE LEAFLET; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; RESIDUE ANALYSIS;

AMINES; CAVEOLIN 1; CAVEOLIN 3; CAVEOLINS; CELL LINE; CELL MEMBRANE; CYTOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR SPACE; FATTY ACIDS; FLUORESCEINS; GENE EXPRESSION REGULATION; MOVEMENT; PHOSPHATIDYLETHANOLAMINES; TRIGLYCERIDES;

EID: 77951032613     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M900251     Document Type: Article

References (49)

1. Meshulam, T., J. R. Simard, J. Wharton, J. A. Hamilton, and P. F. Pilch. 2006. Role of caveolin-1 and cholesterol in transmembrane fatty acid movement. Biochemistry. 45: 2882-2893 (PubMed). (Pubitemid 43334537)
2. Parton, R. G., and K. Simons. 2007. The multiple faces of caveolae. Nat. Rev. Mol. Cell Biol. 8: 185-194 (PubMed).
3. Spisni, E., V. Tomasi, A. Cestaro, and S. C. Tosatto. 2005. Structural insights into the function of human caveolin 1. Biochem. Biophys. Res. Commun. 338: 1383-1390 (PubMed). (Pubitemid 41608405)
4. Dietzen, D. J., W. R. Hastings, and D. M. Lublin. 1995. Caveolin is palmitoylated on multiple cysteine residues. Palmitoylation is not necessary for localization of caveolin to caveolae. J. Biol. Chem. 270: 6838-6842 (PubMed).
5. Monier, S., D. J. Dietzen, W. R. Hastings, D. M. Lublin, and T. V. Kurzchalia. 1996. Oligomerization of VIP21-caveolin in vitro is stabilized by long chain fatty acylation or cholesterol. FEBS Lett. 388: 143-149 (PubMed). (Pubitemid 26226349)
6. Hill, M. M., M. Bastiani, R. Luetterforst, M. Kirkham, A. Kirkham, S. J. Nixon, P. Walser, D. Abankwa, V. M. Oorschot, S. Martin, et al. 2008. PTRF-Cavin, a conserved cytoplasmic protein required for caveola formation and function. Cell. 132: 113-124 (PubMed).
7. Liu, L., D. Brown, M. McKee, N. K. Lebrasseur, D. Yang, K. H. Albrecht, K. Ravid, and P. F. Pilch. 2008. Deletion of Cavin/PTRF causes global loss of caveolae, dyslipidemia, and glucose intolerance. Cell Metab. 8: 310-317 (PubMed).
8. Liu, L., and P. F. Pilch. 2008. A critical role of cavin (polymerase I and transcript release factor) in caveolae formation and organization. J. Biol. Chem. 283: 4314-4322 (PubMed).
9. Cohen, A. W., R. Hnasko, W. Schubert, and M. P. Lisanti. 2004. Role of caveolae and caveolins in health and disease. Physiol. Rev. 84: 1341-1379 (PubMed).
10. Martin, S., and R. G. Parton. 2006. Lipid droplets: a unified view of a dynamic organelle. Nat. Rev. Mol. Cell Biol. 7: 373-378 (PubMed).
11. Pilch, P. F., R. P. Souto, L. Liu, M. P. Jedrychowski, E. A. Berg, C. E. Costello, and S. P. Gygi. 2007. Cellular spelunking: exploring adipocyte caveolae. J. Lipid Res. 48: 2103-2111 (PubMed).
12. Razani, B., T. P. Combs, X. B. Wang, P. G. Frank, D. S. Park, R. G. Russell, M. Li, B. Tang, L. A. Jelicks, P. E. Scherer, et al. 2002. Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities. J. Biol. Chem. 277: 8635-8647 (PubMed). (Pubitemid 34968330)
13. Fujimoto, T., H. Kogo, K. Ishiguro, K. Tauchi, and R. Nomura. 2001. Caveolin-2 is targeted to lipid droplets, a new "membrane domain" in the cell. J. Cell Biol. 152: 1079-1085 (PubMed).
14. Ostermeyer, A. G., J. M. Paci, Y. Zeng, D. M. Lublin, S. Munro, and D. A. Brown. 2001. Accumulation of caveolin in the endoplasmic reticulum redirects the protein to lipid storage droplets. J. Cell Biol. 152: 1071-1078 (PubMed).
15. Pol, A., R. Luetterforst, M. Lindsay, S. Heino, E. Ikonen, and R. G. Parton. 2001. A caveolin dominant negative mutant associates with lipid bodies and induces intracellular cholesterol imbalance. J. Cell Biol. 152: 1057-1070 (PubMed). (Pubitemid 34286080)
16. Brasaemle, D. L., G. Dolios, L. Shapiro, and R. Wang. 2004. Proteomic analysis of proteins associated with lipid droplets of basal and lipolytically stimulated 3T3-L1 adipocytes. J. Biol. Chem. 279: 46835-46842 (PubMed).
17. Liu, P., Y. Ying, Y. Zhao, D. I. Mundy, M. Zhu, and R. G. Anderson. 2004. Chinese hamster ovary K2 cell lipid droplets appear to be metabolic organelles involved in membrane traffic. J. Biol. Chem. 279: 3787-3792 (PubMed). (Pubitemid 38140623)
18. Ost, A., U. Ortegren, J. Gustavsson, F. H. Nystrom, and P. Stralfors. 2005. Triacylglycerol is synthesized in a specific subclass of caveolae in primary adipocytes. J. Biol. Chem. 280: 5-8 (PubMed). (Pubitemid 40164958)
19. Trigatti, B. L., R. G. Anderson, and G. E. Gerber. 1999. Biochem. Biophys. Res. Commun. 255: 34-39 (PubMed).
20. Hamilton, J. A. 2004. Fatty acid interactions with proteins: what X-ray crystal and NMR solution structures tell us. Prog. Lipid Res. 43: 177-199 (PubMed).
21. Guilherme, A., J. V. Virbasius, V. Puri, and M. P. Czech. 2008. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat. Rev. Mol. Cell Biol. 9: 367-377 (PubMed). (Pubitemid 351574198)
22. Unger, R. H. 2002. Lipotoxic diseases. Annu. Rev. Med. 53: 319-336 (PubMed).
23. Schaffer, J. E. 2003. Lipotoxicity: when tissues overeat. Curr. Opin. Lipidol. 14: 281-287 (PubMed).
24. Hoehn, K. L., C. Hohnen-Behrens, A. Cederberg, L. E. Wu, N. Turner, T. Yuasa, Y. Ebina, and D. E. James. 2008. IRS1-independent defects define major nodes of insulin resistance. Cell Metab. 7: 421-433 (PubMed).
25. Koves, T. R., J. R. Ussher, R. C. Noland, D. Slentz, M. Mosedale, O. Ilkayeva, J. Bain, R. Stevens, J. R. Dyck, C. B. Newgard, et al. 2008. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab. 7: 45-56 (PubMed).
26. Shimabukuro, M., Y. T. Zhou, Y. Lee, and R. H. Unger. 1998. Troglitazone lowers islet fat and restores beta cell function of Zucker diabetic fatty rats. J. Biol. Chem. 273: 3547-3550 (PubMed). (Pubitemid 28109778)
27. Dyntar, D., M. Eppenberger-Eberhardt, K. Maedler, M. Pruschy, H. M. Eppenberger, G. A. Spinas, and M. Y. Donath. 2001. Glucose and palmitic acid induce degeneration of myofibrils and modulate apoptosis in rat adult cardiomyocytes. Diabetes. 50: 2105-2113 (PubMed). (Pubitemid 33643679)
28. Wei, Y., D. Wang, F. Topczewski, and M. J. Pagliassotti. 2006. Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells. Am. J. Physiol. Endocrinol. Metab. 291: E275-E281 (PubMed). (Pubitemid 43113013)
29. Listenberger, L. L., D. S. Ory, and J. E. Schaffer. 2001. Palmitate-induced apoptosis can occur through a ceramide-independent pathway. J. Biol. Chem. 276: 14890-14895 (PubMed).
30. Simard, J. R., B. K. Pillai, and J. A. Hamilton. 2008. Fatty acid flip-flop in a model membrane is faster than desorption into the aqueous phase. Biochemistry. 47: 9081-9089 (PubMed).
31. Wharton, J., T. Meshulam, G. Vallega, and P. Pilch. 2005. Dissociation of insulin receptor expression and signaling from caveolin-1 expression. J. Biol. Chem. 280: 13483-13486 (PubMed). (Pubitemid 40517238)
32. Chao, L. C., Z. Zhang, L. Pei, T. Saito, P. Tontonoz, and P. F. Pilch. 2007. Nur77 coordinately regulates expression of genes linked to glucose metabolism in skeletal muscle. Mol. Endocrinol. 21: 2152-2163 (PubMed).
33. Folch, J., M. Lees, and G. H. Sloane Stanley. 1957. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226: 497-509 (PubMed).
34. Zuo, Y., L. Qiang, and S. R. Farmer. 2006. Activation of CCAAT/ enhancer-binding protein (C/EBP) alpha expression by C/EBP beta during adipogenesis requires a peroxisome proliferator-activated receptor-gamma- associated repression of HDAC1 at the C/ebp alpha gene promoter. J. Biol. Chem. 281: 7960-7967 (PubMed). (Pubitemid 43847413)
35. Kamp, F., and J. A. Hamilton. 1992. pH gradients across phospholipid membranes caused by fast flip-flop of un-ionized fatty acids. Proc. Natl. Acad. Sci. USA. 89: 11367-11370 (PubMed).
36. Ridgway, N. D. 2000. Interactions between metabolism and intracellular distribution of cholesterol and sphingomyelin. Biochim. Biophys. Acta. 1484: 129-141 (PubMed).
37. Haynes, M. P., M. C. Phillips, and G. H. Rothblat. 2000. Efflux of cholesterol from different cellular pools. Biochemistry. 39: 4508-4517 (PubMed).
38. Guo, W., N. Huang, J. Cai, W. Xie, and J. A. Hamilton. 2006. Fatty acid transport and metabolism in HepG2 cells. Am. J. Physiol. Gastrointest. Liver Physiol. 290: G528-G534 (PubMed).
39. Kamp, F., W. Guo, R. Souto, P. F. Pilch, B. E. Corkey, and J. A. Hamilton. 2003. Rapid flip-flop of oleic acid across the plasma membrane of adipocytes. J. Biol. Chem. 278: 7988-7995 (PubMed). (Pubitemid 36800537)
40. Asawakarn, T., J. Cladera, and P. O'Shea. 2001. Effects of the membrane dipole potential on the interaction of saquinavir with phospholipid membranes and plasma membrane receptors of Caco-2 cells. J. Biol. Chem. 276: 38457-38463 (PubMed). (Pubitemid 37371197)
41. O'Shea, P. 2005. Physical landscapes in biological membranes: physico-chemical terrains for spatio-temporal control of biomolecular interactions and behaviour. Philos Transact A Math Phys. Eng. Sci. 363: 575-588. (Pubitemid 40176990)
42. Wall, J., F. Ayoub, and P. O'Shea. 1995. Interactions of macromolecules with the mammalian cell surface. J. Cell Sci. 108: 2673-2682 (PubMed).
43. Civelek, V. N., J. A. Hamilton, K. Tornheim, K. L. Kelly, and B. E. Corkey. 1996. Intracellular pH in adipocytes: effects of free fatty acid diffusion across the plasma membrane, lipolytic agonists, and insulin. Proc. Natl. Acad. Sci. USA. 93: 10139-10144 (PubMed).
44. Brasaemle, D. L. 2007. Thematic review series: adipocyte biology. The perilipin family of structural lipid droplet proteins: stabilization of lipid droplets and control of lipolysis. J. Lipid Res. 48: 2547-2559 (PubMed).
45. Febbraio, M., N. A. Abumrad, D. P. Hajjar, K. Sharma, W. Cheng, S. F. Pearce, and R. L. Silverstein. 1999. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J. Biol. Chem. 274: 19055-19062 (PubMed). (Pubitemid 129519326)
46. Lobo, S., B. M. Wiczer, A. J. Smith, A. M. Hall, and D. A. Bernlohr. 2007. Fatty acid metabolism in adipocytes: functional analysis of fatty acid transport proteins 1 and 4. J. Lipid Res. 48: 609-620 (PubMed). (Pubitemid 46397464)
47. Cnop, M., J. C. Hannaert, A. Hoorens, D. L. Eizirik, and D. G. Pipeleers. 2001. Inverse relationship between cytotoxicity of free fatty acids in pancreatic islet cells and cellular triglyceride accumulation. Diabetes. 50: 1771-1777 (PubMed). (Pubitemid 33641595)
48. Le Lay, S., E. Hajduch, M. R. Lindsay, X. Le Liepvre, C. Thiele, P. Ferre, R. G. Parton, T. Kurzchalia, K. Simons, and I. Dugail. 2006. Cholesterol-induced caveolin targeting to lipid droplets in adipocytes: a role for caveolar endocytosis. Traffic. 7: 549-561 (PubMed). (Pubitemid 44026753)
49. Stralfors, P. 1990. Autolysis of isolated adipocytes by endogenously produced fatty acids. FEBS Lett. 263: 153-154 (PubMed). (Pubitemid 20107800)